Agonist erythropoietin receptor antibodies

Details Agonist erythropoietin receptor antibodies Agonist erythropoietin receptor antibodies

C - Chemistry, Metallurgy

07

K

C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 7/06 (2006.01)

Patent

CA 2650131

A genus of erythropoietin (Epo) receptor agonists having unique structural, biochemical, and physiological characteristics has been discovered and is referred to herein as Erythropoietin Receptor Extended Duration Limited Agonists (EREDLA).

L'invention concerne la découverte d'un genre d'agonistes du récepteur d'érythropoïétine (Epo) présentant des caractéristiques structurelles, biochimiques, et physiologiques uniques, que l'on a appelé Agonistes limités à durée prolongée du récepteur d'Erythropoïétine (Erythropoietin Receptor Extended Duration Limited Agonists (EREDLA)).

Affiliated with

Also associated with

Rating

Agonist erythropoietin receptor antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agonist erythropoietin receptor antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agonist erythropoietin receptor antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1907637